Ugandan Non-Communicable Diseases and Aging Cohort (UGANDAC)
Epidemiology of Atherosclerosis Among Older-Age People in Southwestern Uganda
Sponsor: Harvard University
A observational or N/A phase clinical study on Atherosclerosis and Cardiovascular Disease, this trial is completed. The trial is conducted by Harvard University and has accumulated 13 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Apr 2019 — Nov 2020 [monthly]
Completed
-
Feb 2019 — Apr 2019 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Harvard University
- Massachusetts General Hospital
- Mbarara University of Science and Technology
- National Institutes of Health (NIH)
- Ragon Institute of MGH, MIT and Harvard
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .